PERSPECTA

News from every angle

← Back to headlines

Eli Lilly (LLY) Releases Positive Results From Phase 3 VIVID-2 Open-Label Extension Study

25 Feb, 16:10 — 25 Feb, 16:10
PostShare
ℹOnly 1 source covers this story

Read at source (1 outlet)

Yahoo2h ago

Eli Lilly (LLY) Releases Positive Results From Phase 3 VIVID-2 Open-Label Extension Study

Read full article →

Related Stories

Solon: Study-for-work for med-tech students can solve manpower woes

just now

Atara Biotherapeutics Stock Jumps on FDA Cell Therapy Report

13m ago

Telangana Government Launches IVF Services to Address Infertility

20m ago

Swedish Agency Accused of Ignoring Research Fraud on 'Imid Drugs'

25m ago